» Articles » PMID: 39202339

Identification of Gene Regulatory Networks in B-Cell Progenitor Differentiation and Leukemia

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2024 Aug 29
PMID 39202339
Authors
Affiliations
Soon will be listed here.
Abstract

Pro-B- and pre-B-cells are consecutive entities in early B-cell development, representing cells of origin for B-cell precursor acute lymphoid leukemia (BCP-ALL). Normal B-cell differentiation is critically regulated by specific transcription factors (TFs). Accordingly, TF-encoding genes are frequently deregulated or mutated in BCP-ALL. Recently, we described TF-codes which delineate physiological activities of selected groups of TF-encoding genes in hematopoiesis including B-cell development. Here, we exploited these codes to uncover regulatory connections between particular TFs in pro-B- and pre-B-cells via an analysis of developmental TFs encoded by NKL and TALE homeobox genes and by ETS and T-box genes. Comprehensive expression analyses in BCP-ALL cell lines helped identify validated models to study their mutual regulation in vitro. Knockdown and overexpression experiments and subsequent RNA quantification of TF-encoding genes in selected model cell lines revealed activating, inhibitory or absent connections between nine TFs operating in early B-cell development, including HLX, MSX1, IRX1, MEIS1, ETS2, ERG, SPIB, EOMES, and TBX21. In addition, genomic profiling revealed BCP-ALL subtype-specific copy number alterations of at 21q22, while a deletion of the TGFbeta-receptor gene at 3p24 resulted in an upregulation of . Finally, we combined the data to uncover gene regulatory networks which control normal differentiation of early B-cells, collectively endorsing more detailed evaluation of BCP-ALL subtypes.

Citing Articles

IRX-related homeobox gene MKX is a novel oncogene in acute myeloid leukemia.

Nagel S, Meyer C, Pommerenke C PLoS One. 2024; 19(12):e0315196.

PMID: 39689089 PMC: 11651569. DOI: 10.1371/journal.pone.0315196.

References
1.
Bungaro S, Campo DellOrto M, Zangrando A, Basso D, Gorletta T, Lo Nigro L . Integration of genomic and gene expression data of childhood ALL without known aberrations identifies subgroups with specific genetic hallmarks. Genes Chromosomes Cancer. 2008; 48(1):22-38. DOI: 10.1002/gcc.20616. View

2.
Nagel S, Meyer C . Normal and Aberrant TALE-Class Homeobox Gene Activities in Pro-B-Cells and B-Cell Precursor Acute Lymphoblastic Leukemia. Int J Mol Sci. 2022; 23(19). PMC: 9570312. DOI: 10.3390/ijms231911874. View

3.
Kodgule R, Goldman J, Monovich A, Saari T, Aguilar A, Hall C . ETV6 Deficiency Unlocks ERG-Dependent Microsatellite Enhancers to Drive Aberrant Gene Activation in B-Lymphoblastic Leukemia. Blood Cancer Discov. 2022; 4(1):34-53. PMC: 9820540. DOI: 10.1158/2643-3230.BCD-21-0224. View

4.
van Dongen J, Macintyre E, Gabert J, Delabesse E, Rossi V, Saglio G . Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999; 13(12):1901-28. DOI: 10.1038/sj.leu.2401592. View

5.
Hirabayashi S, Ohki K, Nakabayashi K, Ichikawa H, Momozawa Y, Okamura K . ZNF384-related fusion genes define a subgroup of childhood B-cell precursor acute lymphoblastic leukemia with a characteristic immunotype. Haematologica. 2016; 102(1):118-129. PMC: 5210242. DOI: 10.3324/haematol.2016.151035. View